Loading…
Reported covered position: Sr. Advisor, Rep. Gregory Meeks (D-NY)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Biosimilars Access and Affordability Act
Client: AMGEN INC. · Firm: EMPIRE CONSULTING GROUP
HR 10628, Biosimilars Access and Affordability
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues related to Kidney health, HR 1227 Alternatives to Pain Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BUSINESS ROUNDTABLE via EMPIRE CONSULTING GROUP
2026 · third_quarter · RR
Issues pertaining to economic policies and American competitiveness.
KALSHI INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · RR
Source: Senate LDA
| AMGEN, INC. |
| 46 |
| 2015–2026 |
| GILEAD SCIENCES, INC. | 43 | 2016–2026 |
| CTIA | 36 | 2018–2026 |
| WALMART INC | 31 | 2018–2026 |
| BOEING COMPANY | 27 | 2020–2026 |
| THE COCA-COLA COMPANY | 27 | 2016–2026 |
| 4DD SOFTWARE | 24 | 2013–2024 |
| VERTEX PHARMACEUTICALS INCORPORATED | 22 | 2021–2026 |
| BANK OF AMERICA CORPORATION | 21 | 2021–2026 |
| PFIZER, INC. | 19 | 2019–2022 |
| 3SIXTY | 18 | 2021–2025 |
| MEHARRY MEDICAL COLLEGE | 18 | 2018–2021 |
| ADVANCED TECHNOLOGY INTERNATIONAL | 17 | 2022–2026 |
| KODIAK ROBOTICS | 16 | 2023–2026 |
| UNITED STATES TELECOM ASSOCIATION | 15 | 2021–2024 |
| CISCO SYSTEMS, INC. | 12 | 2024–2026 |
| EXXON MOBIL CORP | 12 | 2024–2026 |
| HANNEGAN LANDAU POERSCH & ROSENBAUM ADVOCACY LLC (FOR PALANTIR TECHNOLOGIES INC) | 12 | 2021–2023 |
| MIAMI-DADE COUNTY | 12 | 2024–2026 |
| VISA, INC. | 12 | 2011–2013 |
| WYNN RESORTS DEVELOPMENT, LLC | 11 | 2023–2025 |
| BLACKROCK FUNDS SERVICES GROUP, LLC | 10 | 2024–2026 |
| CRISPR THERAPEUTICS, INC. | 10 | 2019–2021 |
| NAVIENT SOLUTIONS INC. | 10 | 2015–2017 |
| HOTWIRE COMMUNICATIONS LTD. | 9 | 2024–2026 |
| AETNA INC | 8 | 2015–2017 |
| GROCERY MANUFACTURERS OF AMERICA | 8 | 2014–2016 |
| REWORLD WASTE, LLC | 8 | 2025–2026 |
| SP PLUS CORPORATION | 8 | 2023–2024 |
| TURO | 8 | 2025–2026 |
| COALITION FOR EDUCATIONAL SUCCESS | 7 | 2011–2012 |
| CONSTELLATION BRANDS, INC | 7 | 2023–2024 |
| TRANSIT LABS | 7 | 2022–2024 |
| ACLIMA, INC. | 6 | 2022–2023 |
| FOX CORPORATION | 6 | 2023–2024 |
| FRANCIS ENERGY | 6 | 2023–2024 |
| MANAGED FUNDS ASSOCIATION | 6 | 2021–2022 |
| AMERICAN BANKERS ASSOCIATION | 5 | 2025–2026 |
| CALIFORNIA STATE UNIVERSITY, SACRAMENTO (SACRAMENTO STATE) | 5 | 2025–2026 |
| SSP AMERICA | 5 | 2025–2026 |
| AMERICAN TECHNOLOGY SERVICES LLC | 4 | 2023 |
| WEST REALM SHIRES SERVICES INC. D/B/A FTX US | 4 | 2022 |
| CELGENE CORPORATION | 3 | 2016 |
| ALTRIA CLIENT SERVICES, LLC | 2 | 2026 |
| ASTRION | 2 | 2025–2026 |
| BUSINESS ROUNDTABLE | 1 | 2026 |
| KALSHI INC. | 1 | 2026 |
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues related to HR 1227, Alternatives to Pain Act
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 1227, Alternatives to PAIN Act.
Stopping the Theft and Destruction of Broadband Act of 2025
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
Stopping the Theft and Destruction of Broadband Act of 2025
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
HR 2784-Stopping Theft and Destruction of Broadband Act
Stopping the Theft and Destruction of Broadband Act of 2025
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
To require the Director of the Court Services and Offender Supervision Agency for the District of Columbia and the Director of the Pretrial Services Agency for the District of Columbia to reside in the District of Columbia.
Client: WALMART INC. · Firm: EMPIRE CONSULTING GROUP
Discussions regarding the elimination of the penny, H.R. 3047, Common Cents Act.
Main Street Capital Access Act
Client: AMERICAN BANKERS ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
H.R. 6955 Main Street Capital Access Act and the ROAD Act.
Recycled Materials Attribution Act of 2026
Client: EXXON MOBIL CORP. · Firm: EMPIRE CONSULTING GROUP
HR 7502-Recycled Materials Attribution Act (RMAA).
Recycled Materials Attribution Act of 2026
Client: EXXON MOBIL CORP. · Firm: EMPIRE CONSULTING GROUP
HR 7502-Recycled Materials Attribution Act (RMAA).
Farm, Food, and National Security Act of 2026
Client: THE COCA-COLA COMPANY · Firm: EMPIRE CONSULTING GROUP
Issues related to the Food, Farm and National Security Act of 2026 (HR 7567).
Issues related to HR 8870, Build America 250 Act.
Tax Exempt Hospital Transparency Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
HR 9504-The Tax-Exempt Hospital Transparency Act. 340B Program Violations. PBM reform. Issues related to Most Favored Nations. Issues related to health access.
10 Percent Credit Card Interest Rate Cap Act
Client: AMERICAN BANKERS ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
Issues related to the Financial Stability Oversight Council. S.381-10 Percent Credit Card Interest Rate Cap Act. The Road Act.
10 Percent Credit Card Interest Rate Cap Act
Client: AMERICAN BANKERS ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
S.381, 10 Percent Credit Card Interest Rate Cap Act. SCAM Act. Main Street Community Banking.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 1227, Alternatives to PAIN Act.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 1227, Alternatives to PAIN Act.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 1227, Alternatives to PAIN Act; issues related to CMMIs Cell and Gene Therapy Access model for Sickle Cell Disease.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 1227, Alternatives to PAIN Act.
Stopping the Theft and Destruction of Broadband Act of 2025
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
To require the Director of the Court Services and Offender Supervision Agency for the District of Columbia and the Director of the Pretrial Services Agency for the District of Columbia to reside in the District of Columbia.
Client: WALMART INC. · Firm: EMPIRE CONSULTING GROUP
Discussions regarding the elimination of the penny, H.R. 3047, Common Cents Act.
AMERICA DRIVES Act
Client: KODIAK AI, INC. (FORMERLY KODIAK ROBOTICS) · Firm: EMPIRE CONSULTING GROUP
Defense Appropriations Act for FY 2026. HR 4661-The America Drives Act. Army acquisition issues.
National Defense Authorization Act for Fiscal Year 2026
Client: ADVANCED TECHNOLOGY INTERNATIONAL · Firm: EMPIRE CONSULTING GROUP
S.2296, National Defense Authorization Act for 2026. Issues related to defense modernization. Ships for America Act. Issues related to defense acquisitions.
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to Gilead Sciences' drug portfolio. HR 235-Triple Negative Breast Cancer Research & Education.
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to Gilead Sciences' drug portfolio. HR 235-Triple Negative Breast Cancer Research & Education. Clinical trial results for Lenacapavir.
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to Gilead Sciences' drug portfolio. HIV/AIDS funding. HR 235 Triple Negative Breast Cancer Research & Education.
No Free TRIPS Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to insulin. HR 3858, No Free TRIPS Act. Issues related to drug pricing. PDUFA. Health Access & Equity. Pharmacy Benefit Manager Reform Act. 340B. Supplemental funding.
Issues related to broadband. Issues related to Net Neutrality. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA. Issues related to 5G. Affordable Connectivity Program. Issues related to spectrum policy.
Issues related to broadband. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776, National Defense Authorization Act. Issues related to 5G.
Issues related to broadband. Issues related to Net Neutrality. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA. Issues related to 5G. Affordable Connectivity Program. Issues related to spectrum policy.
NTIA Reauthorization Act of 2024
Client: UNITED STATES TELECOM ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband and the Affordable Connectivity Program (ACP). Issues related to lead cables. Universal Service Fund Reform. HR 4510, NTIA Reauthorization Act. Issues related to Net Neutrality.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 7142, Alternatives to PAIN Act. S.127, Pharmacy Benefits Manager Transparency Act. Issues related to CMMIs Cell and Gene Therapy Access model for Sickle Cell Disease.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to cell and gene therapy. HR 7142, Alternatives to PAIN Act. S.127, Pharmacy Benefits Manager Transparency Act.
Issues related to broadband. Issues related to Net Neutrality. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA. Issues related to 5G. Affordable Connectivity Program. Issues related to spectrum policy.
Issues related to broadband. Issues related to Net Neutrality. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA. Issues related to 5G. Affordable Connectivity Program. Issues related to spectrum policy.
Issues related to broadband. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776, National Defense Authorization Act. Issues related to 5G.
21st Century Peace through Strength Act
Client: WALMART INC. · Firm: EMPIRE CONSULTING GROUP
Discussions regarding definitions in HR 8038-21st Century Peace through Strength Act.
Pharmacy Benefit Manager Transparency Act of 2023
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to cell and gene therapy. FY 2025 Appropriations Act. S.3832-Alternative to PAIN Act. S.127-Pharmacy Benefits Manager Transparency Act. Health equity/disparities.
Pharmacy Benefit Manager Transparency Act of 2023
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 7142, Alternatives to PAIN Act. S.127, Pharmacy Benefits Manager Transparency Act. Issues related to CMMIs Cell and Gene Therapy Access model for Sickle Cell Disease.
Pharmacy Benefit Manager Transparency Act of 2023
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to cell and gene therapy. HR 7142, Alternatives to PAIN Act. S.127, Pharmacy Benefits Manager Transparency Act.
Children and Teens’ Online Privacy Protection Act
Client: CTIA · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband. Issues related to Net Neutrality. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA. Issues related to 5G. Affordable Connectivity Program. Issues related to spectrum policy.
Children and Teens’ Online Privacy Protection Act
Client: CTIA · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband. Issues related to Net Neutrality. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA. Issues related to 5G. Affordable Connectivity Program. Issues related to spectrum policy.
Children and Teens’ Online Privacy Protection Act
Client: CTIA · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776, National Defense Authorization Act. Issues related to 5G.
Modernizing and Ensuring PBM Accountability Act
Client: AMGEN INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to the Modernizing and Ensuring PBM Accountability Act (S. 2973). Issues related to the Continuing Appropriations and Disaster Relief Supplemental Appropriations Act of 2025
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to cell and gene therapy. FY 2025 Appropriations Act. S.3832-Alternative to PAIN Act. S.127-Pharmacy Benefits Manager Transparency Act. Health equity/disparities.
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to Gilead Sciences' drug portfolio. WH Cancer Moonshot program. HIV/AIDS funding. HR 235, Triple Negative Breast Cancer Research & Education
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to Gilead Sciences' drug portfolio. WH Cancer Moonshot program. HIV/AIDS funding. HR 235 Triple Negative Breast Cancer Research & Education
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to Gilead Sciences' drug portfolio. HIV/AIDS funding. HR 235 Triple Negative Breast Cancer Research & Education. 340B.
HR 3565. Issues related to Affordable Connectivity Program ("ACP"). Issues related to broadband. Non-approved Devices & Contraband Electronics. Issues related to 988 implementation. NDAA. Issues pertaining to Artificial Intelligence.
Fiscal Responsibility Act of 2023
Client: UNITED STATES TELECOM ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband and the Affordable Connectivity Program (ACP). HR 3746. Farm Bill. Issues related to Artificial Intelligence.
No Free TRIPS Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to insulin. HR 3858, No Free TRIPS Act. Issues related to drug pricing.
No Free TRIPS Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to insulin. HR 3858, No Free TRIPS Act. Issues related to drug pricing. PDUFA. Health Access & Equity. Pharmacy Benefit Manager Reform Act. 340B
No Free TRIPS Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to insulin. HR 3858 No Free TRIPS Act.
Issues related to broadband. Issues related to Non-Approved Devices & Contraband Electronics. Issues related to 988 implementation. S.1418, the Children & Teens Online Privacy Protection Act. S.1080, the Cooper Davis Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA.
NTIA Reauthorization Act of 2024
Client: UNITED STATES TELECOM ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband and the Affordable Connectivity Program (ACP). Issues related to lead cables. Universal Service Fund Reform. HR 4510, NTIA Reauthorization Act. Issues related to Net Neutrality. Telephone Robocall Abuse Criminal Enforcement & Deterrence (TRACED).
Issues related to broadband Issues related to Net Neutrality. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA. Issues related to 5G.
NTIA Reauthorization Act of 2024
Client: UNITED STATES TELECOM ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband and the Affordable Connectivity Program (ACP). Issues related to lead cables. Universal Service Fund Reform. HR 4510, NTIA Reauthorization Act. Issues related to robocalls (TRACED Act).
Issues related to broadband Issues related to Net Neutrality. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA. Issues related to 5G.
Issues related to broadband. Issues related to Non-Approved Devices & Contraband Electronics. Issues related to 988 implementation. S.1418, the Children & Teens Online Privacy Protection Act. S.1080, the Cooper Davis Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA.
S. 1073, Advertising Middlemen Endangering Rigorous Internet Competition Accountability Act (AMERICA Act)
S. 1073, Advertising Middlemen Endangering Rigorous Internet Competition Accountability Act (AMERICA Act)
Issues related to broadband. Issues related to Non-Approved Devices & Contraband Electronics. Issues related to 988 implementation. S.1418, the Children & Teens Online Privacy Protection Act. S.1080, the Cooper Davis Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA.
Children and Teens’ Online Privacy Protection Act
Client: CTIA · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband. Issues related to Non-Approved Devices & Contraband Electronics. Issues related to 988 implementation. S.1418, the Children & Teens Online Privacy Protection Act. S.1080, the Cooper Davis Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA.
Children and Teens’ Online Privacy Protection Act
Client: CTIA · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband Issues related to Net Neutrality. S.1418, the Children & Teens Online Privacy Protection Act. HR 4510, NTIA Reauthorization Act. HR 7776 NDAA. Issues related to 5G.
Issues related to commercial banking. Senate Oversight Hearing on SEC. S.2860, the Safer Banking Act. Issues Pertaining to Artificial Intelligence.
Protecting Seniors Through Immunization Act of 2021
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
Protecting Seniors Through Immunization Act of 2021
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
Protecting Seniors Through Immunization Act of 2021
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to COVID-19; drug pricing proposals; and HR 3927/S.2082 (MADE in America Act); Build Back Better; HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; and HR 3656/S.3087: Issues related to the Vaccine Injury Compensation Program.
Protecting Seniors Through Immunization Act of 2021
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
Issues pertaining to COVID-19; drug pricing proposals; and HR 3927/S.2082 (MADE in America Act); Build Back Better; HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; and HR 3656/S.3087: Issues related to the Vaccine Injury Compensation Program.
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
Issues pertaining to COVID-19; drug pricing proposals; and HR 3927/S.2082 (MADE in America Act).
Issues pertaining to COVID-19; drug pricing proposals; and HR 3927/S.2082 (MADE in America Act); Build Back Better; HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; and HR 3656/S.3087: Issues related to the Vaccine Injury Compensation Program.
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
United States Innovation & Competition Act; issues related to the reauthorization of the FCC's spectrum auction authority; HR 678-the Phone Act; and HR 8152, the American Data Privacy & Protection Act.
United States Innovation & Competition Act; HR 7598-Robocall Trace Back Enhancement Act; HR 678-the Phone Act; and HR 7900-National Defense Authorization Act.
Issues related to infrastructure, spectrum policy, and combatting illegal robocall; HR 8152-the American Data & Privacy Act; the National Defense Authorization Act; HR 7132-the Safe Connections Act of 2022; and the United States Innovation & Competition Act; and issues
Robocall Trace Back Enhancement Act
Client: UNITED STATES TELECOM ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
United States Innovation & Competition Act; HR 7598-Robocall Trace Back Enhancement Act; HR 678-the Phone Act; and HR 7900-National Defense Authorization Act.
Spectrum Innovation Act of 2022
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband; HR 7624, the Spectrum Innovation Act; National Defense Authorization Act; and Omnibus legislation.
National Defense Authorization Act; HR 7624-Spectrum Innovation Act; Omnibus legislation; and HR 7783-Extending America's Spectrum Auction Leadership Act of 2022.
Extending America’s Spectrum Auction Leadership Act of 2022
Client: CTIA · Firm: EMPIRE CONSULTING GROUP
National Defense Authorization Act; HR 7624-Spectrum Innovation Act; Omnibus legislation; and HR 7783-Extending America's Spectrum Auction Leadership Act of 2022.
National Defense Authorization Act for Fiscal Year 2023
Client: UNITED STATES TELECOM ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
United States Innovation & Competition Act; HR 7598-Robocall Trace Back Enhancement Act; HR 678-the Phone Act; and HR 7900-National Defense Authorization Act.
National Defense Authorization Act for Fiscal Year 2023
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband; the US Innovation & Competition Act (USICA)/America Competes Act; HR 8152-American Data & Privacy Act; and HR 7900-National Defense Authorization Act.
American Data Privacy and Protection Act
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband; the US Innovation & Competition Act (USICA)/America Competes Act; HR 8152-American Data & Privacy Act; and issues related to the reauthorization of the FCC's spectrum authority.
American Data Privacy and Protection Act
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband policy; Inflation Reduction Act; and HR 8152, the American Data Privacy & Protection Act.
American Data Privacy and Protection Act
Client: UNITED STATES TELECOM ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
United States Innovation & Competition Act; issues related to the reauthorization of the FCC's spectrum auction authority; HR 678-the Phone Act; and HR 8152, the American Data Privacy & Protection Act.
American Data Privacy and Protection Act
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband; the US Innovation & Competition Act (USICA)/America Competes Act; HR 8152-American Data & Privacy Act; and HR 7900-National Defense Authorization Act.
Issues related to infrastructure, spectrum policy, and combatting illegal robocall; HR 8152-the American Data & Privacy Act; the National Defense Authorization Act; HR 7132-the Safe Connections Act of 2022; and the United States Innovation & Competition Act; and issues
HR 8152-the American Data & Privacy Act; the National Defense Authorization Act; the United States Innovation & Competition Act; and issues related to the reauthorization of the FCC's spectrum auction authority.
Expressing support for the designation of June 19, 2022, as "World Sickle Cell Awareness Day" in order to increase public alertness across the United States and global community about sickle cell disease, the continued need for empirical research, early detection screenings for sickle cell trait carriers, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions related to sickle cell disease.
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to cell and gene therapies; H. Res 1176 (World Sickle Cell Awareness Day); and issues related to Vertex's scientific advances/innovations and therapies.
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
Issues pertaining to COVID-19; drug pricing proposals; and HR 3927/S.2082 (MADE in America Act).
Issues pertaining to COVID-19; drug pricing proposals; and HR 3927/S.2082 (MADE in America Act); Build Back Better; HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; and HR 3656/S.3087: Issues related to the Vaccine Injury Compensation Program.
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
Issues pertaining to COVID-19; Inflation Reduction Act; HR 3927/S.2082 (MADE in America Act); HR 1978/S.912-Protecting Seniors through Immunization Act of 2021; HR 3656/S.3087 (Vaccine Access Improvement Act): Issues related to the Vaccine Injury Compensation Program; and Continuing Resolution.
Issues related to prediction markets and finance.
Issues related to prediction markets and finance.
WALMART INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to the retail industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALTRIA CLIENT SERVICES, LLC via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to illicit trade and tobacco harm reduction.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLACKROCK FUNDS SERVICES GROUP, LLC via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to energy infrastructure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to the Farm Bill and the food and beverage industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURO via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to surface transportation reauthorization bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BANKERS ASSOCIATION via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
H.R. 6955 Main Street Capital Access Act and the ROAD Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA STATE UNIVERSITY, SACRAMENTO (SACRAMENTO STATE) via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REWORLD WASTE, LLC via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to the environment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXXON MOBIL CORP. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
HR 7502-Recycled Materials Attribution Act (RMAA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CISCO SYSTEMS, INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to AI, and the NDAA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOTWIRE COMMUNICATIONS, LTD. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to telecommunications policy and bulk billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIAMI-DADE COUNTY via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to Miami-Dade airport
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to Kidney health, HR 1227 Alternatives to Pain Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANK OF AMERICA CORPORATION via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to the commercial banking industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEING COMPANY via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to aviation safety, the NDAA, ExIm reauthorization, and government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
NDAA. Issues related to wireless policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to health policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
HR 10628, Biosimilars Access and Affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
HR 2784-Stopping Theft and Destruction of Broadband Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to Name Image Likeness (NIL), and the operational performance of Nike.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to the aviation and trucking industries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to carriage agreements, and Section 815 NDAA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
MFN drug pricing, 340B, PBM reform, and other drug pricing issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES INC via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to aviation safety, Modern Skies Act, government funding, surveillance pricing, and the operational performance of American Airlines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to the Food, Farm and National Security Act of 2026 (HR 7567).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
HR 9504-The Tax-Exempt Hospital Transparency Act. 340B Program Violations. PBM reform. Issues related to Most Favored Nations. Issues related to health access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANK OF AMERICA CORPORATION via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to the commercial banking industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to triple negative breast cancer treatment. Issues related to health access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURO via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to HR 8870, Build America 250 Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BANKERS ASSOCIATION via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
S.381, 10 Percent Credit Card Interest Rate Cap Act. SCAM Act. Main Street Community Banking.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REWORLD WASTE, LLC via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues relating to waste management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLACKROCK FUNDS SERVICES GROUP, LLC via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to data centers/infrastructure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXXON MOBIL CORP. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
HR 7502-Recycled Materials Attribution Act (RMAA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CISCO SYSTEMS, INC. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to Artificial Intelligence, NDAA and Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOTWIRE COMMUNICATIONS, LTD. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to bulk billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIAMI-DADE COUNTY via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues relating to government funding and Brightline.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to HR 1227, Alternatives to Pain Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEING COMPANY via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to appropriations. NDAA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to the wireless industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to health access. PBM reform. Most Favored Nation issues. 340B Reform. Issues related to Womens Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to sports and fitness.
Issues related to NIL.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to the trucking industry and aviation industries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to disaster resilience technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES INC via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Government funding. Issues related to aviation safety and AA flight #5342. Issues related to the operational performance of American Airlines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURO via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Surface Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BANKERS ASSOCIATION via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the Financial Stability Oversight Council. S.381-10 Percent Credit Card Interest Rate Cap Act. The Road Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SSP AMERICA via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to food and beverage at airports.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRION via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
National Defense Authorization Act, FY 2027. Issues related to government technology modernization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA STATE UNIVERSITY, SACRAMENTO (SACRAMENTO STATE) via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to higher education. Government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REWORLD WASTE, LLC via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues relating to sustainability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLACKROCK FUNDS SERVICES GROUP, LLC via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to retirement and infrastructure. Issues related to public utilities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXXON MOBIL CORP. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Advanced recycling. Issues related to the EU's Corporate Sustainability Due Diligence Directive.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CISCO SYSTEMS, INC. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Artificial Intelligence. National Defense Authorization Act (NDAA). Government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIAMI-DADE COUNTY via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Government funding. Issues related to Homeland Security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KODIAK AI, INC. (FORMERLY KODIAK ROBOTICS) via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Defense Appropriations Act for FY 2026 and FY 2027. Defense Authorization Act, FY 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED TECHNOLOGY INTERNATIONAL via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
National Defense Authorization Act for FY2026. Issues related to defense modernization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
HR 1227, Alternatives to PAIN Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANK OF AMERICA CORPORATION via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the commercial banking industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEING COMPANY via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to aviation and defense. Defense Appropriations FY 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALMART INC. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Discussions regarding the elimination of the penny, H.R. 3047, Common Cents Act.
Filing targets: HOUSE OF REPRESENTATIVES
CTIA via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the wireless industry. Government funding. Advancing American WiFi Against Adversaries Act. Issues related to Artificial Intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the food and beverage industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to health access. Issues related to HIV medication.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to health access. PBM reform. Most-Favored-Nation pricing for pharmaceuticals. 340B.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to footwear and sport and health/fitness.
Issues related to the SCORE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the trucking industry and aviation. Government funding. Surface Reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the telecommunications industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
PBM reform. Issues related to health access. 340B reform issues. Issues related to Most-Favored-Nation prescription drug pricing. Tariffs on pharmaceutical products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES INC via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Government funding. NTSB/DCA accident. ROTOR Act. Operational and performance issues for AAL. Issues related to DHS.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALTRIA CLIENT SERVICES, LLC via EMPIRE CONSULTING GROUP
2026 · first_quarter · RR
Issues related to the manufacture, marketing, and sale of tobacco products.
KODIAK AI, INC. (FORMERLY KODIAK ROBOTICS) via EMPIRE CONSULTING GROUP
2025 · second_quarter · 2A
Issues related to the National Defense Authorization Act for 2026. Defense Appropriations Act FY 2026. Transportation issues related to autonomy. Army acquisition issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KODIAK AI, INC. (FORMERLY KODIAK ROBOTICS) via EMPIRE CONSULTING GROUP
2025 · first_quarter · 1A
Issues related to the National Defense Authorization Act. Defense Appropriations Act FY 2026. Transportation issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the food and beverage industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURO via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Surface Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SSP AMERICA via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to food and beverage at airports.
Filing targets: HOUSE OF REPRESENTATIVES
ASTRION via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to government technology modernization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA STATE UNIVERSITY, SACRAMENTO (SACRAMENTO STATE) via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REWORLD WASTE, LLC via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues relating to sustainability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLACKROCK FUNDS SERVICES GROUP, LLC via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to retirement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXXON MOBIL CORP. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Advanced recycling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CISCO SYSTEMS, INC. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Artificial Intelligence. National Defense Authorization Act (NDAA). Government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIAMI-DADE COUNTY via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Appropriations FY2026. Issues related to aviation & MIA airport.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KODIAK AI, INC. (FORMERLY KODIAK ROBOTICS) via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Defense Appropriations Act for FY 2026. HR 4661-The America Drives Act. Army acquisition issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED TECHNOLOGY INTERNATIONAL via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
National Defense Authorization Act for FY2026. Issues related to defense acquisition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
HR 1227, Alternatives to PAIN Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANK OF AMERICA CORPORATION via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the commercial banking industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEING COMPANY via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to aviation and defense.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALMART INC. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Discussions regarding the elimination of the penny, H.R. 3047, Common Cents Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the wireless industry. Government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to health access. Issues related to HIV medication.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to health access. PBM reform. Most-Favored-Nation pricing for pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the SCORE Act.
Issues related to footwear and sports.
Filing targets: HOUSE OF REPRESENTATIVES
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the trucking industry and aviation. Government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the telecommunications industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
PBM reform. Issues related to health access. 340B reform issues. Issues related to Most-Favored-Nation prescription drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE